BioSpace News Archive

Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced topline results from the interchangeability study for SB5, a biosimilar to Humira ® (adalimumab).

Merck, known as MSD outside the United States and Canada, announced financial results for the second quarter of 2023.

Zentalis ® Pharmaceuticals, Inc. today announced the appointment of Kimberly Freeman as Chief Strategy Officer. In this role, she will support and implement Zentalis’ long-term portfolio strategy.

Rhythm Pharmaceuticals, Inc. today reported financial results and provided a business update for the second quarter ended June 30, 2023.

uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial results for the second quarter of 2023 and highlighted recent progress across its business.

Bio-Path Holdings, Inc. reports interim data from Stage 2 of the Company’s Phase 2 study of prexigebersen in combination with decitabine and venetoclax for the treatment of acute myeloid leukemia.

Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced that it plans to release 2023 second quarter financial and operating results after the market closes on Thursday, August 10, 2023.

Eagle Pharmaceuticals, Inc. announced that the Company will release its second quarter 2023 financial results on Tuesday, August 8, 2023, before the market opens.